1. Specific inhibition of in vitro reverse transcription using antisense oligonucleotides targeted to the TAR regions of HIV-1 and HIV-2
- Author
-
Maritta Perala-Heape, Simon Litvak, Leila Sarih-Cottin, and Florence Boulmé
- Subjects
Electrophoresis ,DNA, Complementary ,Molecular Sequence Data ,Ribonuclease H ,Biophysics ,Biology ,Virus Replication ,Biochemistry ,chemistry.chemical_compound ,Structural Biology ,Complementary DNA ,Genetics ,HIV Long Terminal Repeat ,Base Sequence ,Oligonucleotide ,Nucleic Acid Heteroduplexes ,RNA ,RNA-Directed DNA Polymerase ,Oligonucleotides, Antisense ,Molecular biology ,Reverse transcriptase ,In vitro ,HIV Reverse Transcriptase ,chemistry ,Antisense oligonucleotides ,DNA, Viral ,HIV-1 ,RNA, Viral ,Reverse Transcriptase Inhibitors ,DNA - Abstract
Antisense oligonucleotides (ODNs) overlapping the stem-loop structure of the trans-activating responsive (TAR) element at the 5' end of HIV-1 and HIV-2 viral RNAs were tested for their inhibitory effect on cDNA synthesis by HIV-1 and HIV-2 reverse transcriptases (RT). Inhibition of reverse transcription is sequence-specific and enhanced by the presence of the RT-associated RNase H activity. The degree of inhibition obtained with the anti-TAR antisense is significantly higher than with other HIV-1 targeted antisense ODNs used before [1]. Gel retardation showed a stable specific complex between the 16- and 25-mer anti-TAR HIV-1 selected ODNs and the target region. No complex was observed with a non-inhibitor 22-mer anti-TAR ODN and with the corresponding control sequences. Targeting of the first stem-loop in the 5' region of HIV-2 RNA by anti-TAR ODNs inhibited very strongly reverse transcription by HIV-2 RT. The structure of the antisense and the target sequence affect annealing efficiency and hence the degree of inhibition of reverse transcription.
- Published
- 1997